INTRODUCTION
============

Extra-abdominal desmoid tumors (EDT) are a rare condition caused by the proliferation of fibroblasts. Although the tumor is benign, it is locally aggressive, and its unpredictable clinical behavior leads to disagreement regarding its treatment.[@B1] ^,^ [@B2] According to the World Health Organization (WHO), EDT is defined as a monoclonal proliferation of fibroblasts that affects deep soft tissues. It is characterized by infiltrative growth and a tendency toward local recurrence (LR). It does not present distant metastasis (DM).[@B3] EDT can affect any part of the body, but appears more frequently on the limbs and trunk ([Figure 1](#f1){ref-type="fig"}). These tumors are rare, with an incidence of 2-4 cases/1,000,000 individuals in global statistics. Onset ranges from subjects in their 20s to their 70s, with a higher incidence in subjects in their 40s or thereabouts.[@B4] ^-^ [@B6] The treatment of choice is based on resection surgery with negative margins (NM). Clinical surveillance may be used in duly selected cases where constant outpatient follow-up is maintained.[@B7] In view of the local characteristics of EDT, resection with NM represents a challenge to the surgeon. The pattern of growth with projections and the impossibility of distinguishing the capsule during the surgical procedure increase the risk of involvement of the surgical margins, which are frequently mentioned in pathology reports.[@B8] ^-^ [@B11] Therefore adjuvant radiotherapy is a method of choice to avoid LR. When this occurs, it can be isolated or multiple, can acquire a more aggressive biological activity and spread locally.[@B12] ^-^ [@B14] If resection is not possible, pharmacological treatment may be indicated. Pharmacological options include anti-hormonal agents (e.g. tamoxifen), nonsteroidal anti-inflammatory drugs (e.g. celecoxib), and conventional chemotherapy (CT).[@B15] ^,^ [@B16] Ultimately, treatment of the disease should be multidisciplinary, focusing on the quality of life and function of the affected patient.[@B17] The purpose of this research is to present the clinical results obtained in patients with EDT treated at our institution.
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MATERIALS AND METHODS
=====================

The study was approved by the Institutional Review Board of HCFMUSP under number 1174. It is a cross-sectional retrospective study in which 23 medical records of patients diagnosed with EDT by the IOT-HC-FMUSP Orthopedic Oncology Group covering the period from 1995 to 2016 were used. We reviewed 223 medical records, 200 of which were excluded due to lack of data. All patients included in this study received surgical treatment. Age, sex, laterality, date of diagnosis, tumor size, type of surgery and postoperative outpatient follow-up were acquired from the medical records ([Table 1](#t1){ref-type="table"}). The histological diagnosis was made by the pathologists of the institute. The patients' characteristics were described using absolute and relative frequencies, and their age was also described using mean and standard deviation.[@B18] The mean disease-free survival with the respective intervals was estimated with 95% confidence according to characteristics of interest. The mean times were estimated when it was not possible to estimate the median time using the Kaplan-Meier estimator,[@B19] and times were compared between the categories of characteristics using log-rank tests.[@B19] The hazard ratios (HR) of LR-free time were estimated between the categories with the respective 95% confidence intervals using bivariate Cox regression models.[@B19] The tests were conducted with a significance level of 5%.

###### Description of patient demographics.

  Variable                                          Frequency     \%
  ------------------------------------------------- ------------- ------
  **Sex**                                                         
  Female                                            12            52.2
  Male                                              11            47.8
  **Age** [\*](#TFN1){ref-type="table-fn"}                        
  ≤20 years                                         10            45.5
  \>20 years                                        12            54.5
  Mean (SD)                                         22.5 (11.9)   
  **Tumor Site**                                                  
  Lower Limb                                        12            52.2
  Upper Limb                                        7             30.4
  Back                                              4             17.4
  **Laterality** [\*](#TFN1){ref-type="table-fn"}                 
  Right                                             10            47.6
  Left                                              11            52.4
  **Margin**                                                      
  Negative                                          12            52.2
  Positive                                          11            47.8
  **Tumor Size**                                                  
  \<5 cm                                            5             21.7
  ≥5 cm                                             18            78.3
  **Recurrence**                                                  
  No                                                12            52.2
  Yes                                               11            47.8
  Total                                             23            100

RESULTS
=======

A total of 223 medical records with pathology reports were reviewed for this study. Only 23 cases of EDT were included in the present study. The mean age was 22.5 years. Twelve patients were female (52.2%) and eleven male (47.8%). The left side was affected most often with 11 (52.4%) cases, while there were 10 right-sided cases (47.6%) and two cases involving the midline back. Twelve (52.2%) cases were located in the lower limbs, seven (30.4%) cases in the upper limbs, and four (17.4%) cases were located on the back. Regarding tumor size, five (21.7%) cases measured \<5cm and 18 (78.3%) cases measured size \>5cm. All patients received surgical treatment as definitive therapy at the institute. The surgery of choice for all patients was surgical resection with NM. The histopathology reports listed twelve (52.2%) cases with NM and eleven (47.8%) cases with PM. LR occurred in eleven (47.8%) patients. Only the surgical margins influenced the disease-free survival of patients with EDT ([Figure 2](#f2){ref-type="fig"}). Patients with PM presented a 90-fold higher risk of LR when compared to patients with NM (p \<0.001) ([Table 2](#t2){ref-type="table"}).
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###### Mean disease-free survival according to the information resulting from comparative tests.

  Variable                                      Median Time (months)   CI (95%)                           Recurrence                         Total   \%   HR     CI (95%)   p                 
  --------------------------------------------- ---------------------- ---------------------------------- ---------------------------------- ------- ---- ------ ---------- ------ ---------- -------------
  **Sex**                                                                                                                                                                                     **0.24**
  Female                                        96                     34.3                               157.7                              7       12   58.3   1                            
  Male[\*](#TFN1){ref-type="table-fn"}          170.7                  98.1                               243.3                              3       11   27.3   0.43       0.11   1.69       
  **Age**                                                                                                                                                                                     **0.7**
  ≤20 years                                     98                     20.9                               175.1                              5       10   50     1                            
  \>20 years                                    96                     35.7                               156.3                              5       12   41.7   0.78       0.22   2.75       
  **Tumor Site**                                                                                                                                                                              **0.058**
  Lower Limb                                    63                     31.7                               94.3                               7       12   58.3   1                            
  Upper Limb [\*](#TFN1){ref-type="table-fn"}   183.3                  107.8                              258.7                              2       7    28.6   0.11       0.01   0.91       
  Back                                          69                     [\#](#TFN2){ref-type="table-fn"}   [\#](#TFN2){ref-type="table-fn"}   1       4    25     0.86       0.1    7.25       
  **Laterality**                                                                                                                                                                              **0.344**
  Right                                         96                     [\#](#TFN2){ref-type="table-fn"}   [\#](#TFN2){ref-type="table-fn"}   3       10   30     1                            
  Left                                          98                     24.4                               171.6                              6       11   54.5   1.94       0.48   7.84       
  **Margin**                                                                                                                                                                                  **\<0.001**
  Negative                                      252                    [\#](#TFN2){ref-type="table-fn"}   [\#](#TFN2){ref-type="table-fn"}   0       12   0      1                            
  Positive                                      61                     17.6                               104.4                              10      11   90.9   88.34      0.5    15498.91   
  **Tumor Size**                                                                                                                                                                              **0.789**
  \<5 cm                                        98                     52.8                               143.2                              3       5    60     1                            
  ≥5 cm                                         96                     39.4                               152.6                              7       18   38.9   1.21       0.31   4.72       
  Total                                         98                     58                                 138                                10      23   43.5                                

Mean recurrence-free survival.

Cannot be estimated.

DISCUSSION
==========

The literature presents an extensive list of publications on EDT. Most of the published studies are retrospective series and case reports.[@B2] ^,^ [@B6] This study was no exception: we analyzed 23 consecutive cases over 16 years. We did not find many studies addressing EDT in our field. The mean age in our study was 22.5 years, which coincides with that described in the literature.[@B7] ^,^ [@B9] In bibliographical terms, EDT predominates slightly in female subjects.[@B1] In this study we also observed female predominance (52.2%). Published studies indicate that EDT occurs mainly in the abdomen.[@B14] ^,^ [@B15] ^,^ [@B20] This data cannot be compared as the study was conducted at an orthopedic institute. Therefore, we found widespread wide predominance of limb involvement, with a rate of 82.6%. As defined in the literature, the mean preoperative size ranges between 8 and 12 cm.[@B21] In our study the size varied a great deal, yet most cases involved tumors \>5 cm, a fact similar to the published data. We also reported a PM rate of 47.8%. This data is not commonly reported in numerical values in the literature. One of the few studies with this data reported a rate of 42.5%.[@B22] Again, this finding is similar to that of our research. The main complication of EDT is LR, with rates ranging between 40 and 60%.[@B17] ^,^ [@B21] ^,^ [@B23] Our study found a LR rate of 47.8%, again coinciding with the literature. The mean patient follow-up time was 98 months. Finally, we report that surgical margin impairment is directly related to the decrease in disease-free survival of the patient presenting with this tumor.

CONCLUSIONS
===========

Surgical margin impairment was the only prognostic factor found for EDT LR.
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